The approved ANDA is therapeutically equivalent to the reference listed drug product, Durezol ophthalmic emulsion, 0.05% of ...

VADODARA, India, April 12 (Reuters) - Drug maker Alembic Ltd. plans to invest 600 million rupees over two years to set up a drug manufacturing facility even as it looks to bolster its international ...

Alembic Pharmaceuticals Ltd received final approval from the USFDA for its generic Difluprednate ophthalmic emulsion, used to ...

MUMBAI, June 29 (Reuters) - Drugmaker Alembic Ltd said on Tuesday its board approved the demerger of its core pharmaceuticals business into a separate unit, paving the way for the company's entry into ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Alembic Ltd, Dodla Dairy, Intellect Design Arena, and IFB Industries have shown bullish technical patterns alongside strong financial performance, according to SEBI-registered analyst Gunjan Kumar.

Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2025 - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with ...

Case Name: Adverio Pharma Gmbh v. Alembic Pharms. Ltd., C.A. No. 18-73-LPS, 2019 U.S. Dist. LEXIS 23021 (D. Del. Feb. 13, 2019) (Stark, J.) Nature of Case and Issue(s) Presented: Plaintiffs have legal ...

Alembic Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its generic version of Difluprednate ophthalmic emulsion used to treat eye inflammation and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...